UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?

Current atherosclerosis reports, 2023-07, Vol.25 (7), p.381-389

2023

Volltextzugriff (PDF)

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502

2016

Volltextzugriff (PDF)

Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease

Journal of Cardiovascular Pharmacology and Therapeutics, 2022-01, Vol.27, p.10742484211056115-10742484211056115

2022

Volltextzugriff (PDF)

Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD

Journal of the American Heart Association, 2022-06, Vol.11 (12), p.e024655-e024655

2022

Volltextzugriff (PDF)

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions

Journal of cardiovascular development and disease, 2023-04, Vol.10 (4), p.164

2023

Volltextzugriff (PDF)

Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study

Journal of the American Heart Association, 2017-10, Vol.6 (10), p.n/a

2017

Volltextzugriff (PDF)

Risk of remnants and remnant risk in peripheral artery disease

European heart journal, 2022-09, Vol.43 (34), p.3270-3272

2022

Volltextzugriff (PDF)

Guideline-Directed Medical Therapy in PAD: Time to Step on the Gas

JACC. Cardiovascular interventions, 2023-02, Vol.16 (3), p.344-346

2023

Volltextzugriff (PDF)

ASCVD Risk and Statin Use in PAD: Implementing a New Approach to an Old Problem

Journal of the American College of Cardiology, 2020-07, Vol.76 (3), p.265-267

2020

Volltextzugriff (PDF)

Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back

European heart journal, 2020-05, Vol.41 (17), p.1650-1652

2020

Volltextzugriff (PDF)

Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease

Circulation. Cardiovascular interventions, 2020-10, Vol.13 (10), p.e009584-e009584

2020

Volltextzugriff (PDF)

Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization

Journal of the American College of Cardiology, 2020-02, Vol.75 (5), p.498-508

2020

Volltextzugriff (PDF)

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2534-2555

2017

Volltextzugriff (PDF)

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Circulation (New York, N.Y.), 2019-08, Vol.140 (7), p.556-565

2019

Volltextzugriff (PDF)

Sex differences in guideline-directed medical therapy in 2021–22 among patients with peripheral artery disease

Vascular medicine (London, England), 2023-06, Vol.28 (3), p.233-235

2023

Volltextzugriff (PDF)

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Circulation (New York, N.Y.), 2020-12, Vol.142 (23), p.2219-2230

2020

Volltextzugriff (PDF)

2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2021-02, Vol.77 (6), p.811-825

2021

Volltextzugriff (PDF)

Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention

Circulation. Cardiovascular interventions, 2022-08, Vol.15 (8), p.e011768

2022

Volltextzugriff (PDF)

Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease

Journal of the American College of Cardiology, 2021-06, Vol.77 (24), p.3016-3027

2021

Volltextzugriff (PDF)

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Journal of the American College of Cardiology, 2021-07, Vol.78 (4), p.317-326

2021

Volltextzugriff (PDF)

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

European heart journal, 2023-10, Vol.44 (39), p.4157-4173

2023

Volltextzugriff (PDF)

Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease

Journal of the American College of Cardiology, 2024-06, Vol.83 (25), p.2658-2670

2024

Volltextzugriff (PDF)

Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication

JACC. Cardiovascular interventions, 2023-07, Vol.16 (13), p.1668-1678

2023

Volltextzugriff (PDF)

Heterogeneity of Risk and Benefit in Subgroups of COMPASS: Relatively Similar But Absolutely Different

Journal of the American College of Cardiology, 2019-07, Vol.73 (25), p.3292-3294

2019

Volltextzugriff (PDF)

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2023-12, Vol.148 (24), p.1919

2023

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Englisch
(84)
Norwegisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease

Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions

Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study

Risk of remnants and remnant risk in peripheral artery disease

Guideline-Directed Medical Therapy in PAD: Time to Step on the Gas

ASCVD Risk and Statin Use in PAD: Implementing a New Approach to an Old Problem

Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back

Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease

Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Sex differences in guideline-directed medical therapy in 2021–22 among patients with peripheral artery disease

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee

Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention

Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease

Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication

Heterogeneity of Risk and Benefit in Subgroups of COMPASS: Relatively Similar But Absolutely Different

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Aktive Filter

Suchergebnisse filtern